Results 81 to 90 of about 16,074 (250)

Retrospective analysis of the tolerability and effectiveness of rimegepant for the acute treatment of migraine in adolescents

open access: yesHeadache: The Journal of Head and Face Pain, Volume 66, Issue 4, Page 829-834, April 2026.
Abstract Objective This study aims to evaluate the tolerability and effectiveness of the off‐label use of rimegepant as acute migraine treatment in adolescents. Background Calcitonin gene‐related peptide (CGRP) levels are elevated during migraine attacks.
Konstantinos Tourlas   +4 more
wiley   +1 more source

Triptans in the acute treatment of migraine: A systematic review and network meta-analysis. [PDF]

open access: yes, 2015
BACKGROUND: Although triptans are widely used in the acute management of migraine, there is uncertainty around the comparative efficacy of triptans among each other and vs non-triptan migraine treatments.
Ades   +25 more
core   +1 more source

Long COVID Syndrome and Associated New Daily Persistent Headache (NDPH) Presenting With Crossed Clonus Response

open access: yesClinical Case Reports, Volume 14, Issue 3, March 2026.
ABSTRACT Evaluating patients following a COVID‐19 infection with multiple chronic, progressive symptoms can be challenging, but easy to navigate by using the temporal profile obtained from the clinical history, findings from the neurological exam, and screening for red flag symptoms.
Emma Wetmore   +4 more
wiley   +1 more source

Harnessing Intranasal Delivery Systems of Sumatriptan for the Treatment of Migraine [PDF]

open access: hybrid, 2022
Sara Assadpour   +4 more
openalex   +1 more source

Topiramate‐induced acute angle closure with suprachoroidal effusion: Insights from a novel ultra‐wide‐field OCT device

open access: yes
Acta Ophthalmologica, Volume 104, Issue 3, Page e356-e359, May 2026.
Michael Hafner   +6 more
wiley   +1 more source

Investigations with GMC2021 in experimental models predictive of antimigraine activity and coronary side-effect potential [PDF]

open access: yes, 1996
Several acutely acting antimigraine drugs, including sumatriptan and other second generation 5-HT1D receptor agonists, have the ability to constrict porcine carotid arteriovenous anastomoses as well as the human isolated coronary artery.
Barf, R.P. (Paulien)   +6 more
core   +1 more source

Neuro‐Immune Crosstalk: Molecular Mechanisms, Biological Functions, Diseases, and Therapeutic Targets

open access: yesMedComm, Volume 7, Issue 2, February 2026.
Neurons, immune cells, and other cellular components within the disease microenvironment (such as stromal cells and tumor cells) constitute a dynamically evolving ecosystem. Neurons directly modulate immune cell activity and inflammatory responses through the release of neurotransmitters (e.g., norepinephrine and CGRP), while also promoting tumor ...
Xin Guo   +11 more
wiley   +1 more source

Interictal and postictal cognitive changes in migraine [PDF]

open access: yes, 1999
The question whether symptom-free migraine patients show cognitive impairments compared to matched control subjects is addressed, and also whether migraine patients show transient cognitive impairments induced by an attack.
Geus, E.J.C. de   +4 more
core   +2 more sources

Regulatory T cells require peripheral CCL2-CCR2 signaling to facilitate the resolution of medication overuse headache-related behavioral sensitization

open access: yesThe Journal of Headache and Pain
Background Medication overuse headache (MOH) is the most common secondary headache disorder, resulting from chronic and excessive use of medication to treat headaches, for example, sumatriptan.
Sun Ryu   +8 more
doaj   +1 more source

Home - About - Disclaimer - Privacy